These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 2454372

  • 1. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B, Cronin CJ, Graham BR, Prichard BN.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [Abstract] [Full Text] [Related]

  • 2. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B, Bompart F, Graham BR, Liu JB, Prichard BN.
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [Abstract] [Full Text] [Related]

  • 3. Vasodilatory effects of carvedilol and pindolol.
    Sundberg S, Tiihonen K, Gordin A.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S76-80. PubMed ID: 2454373
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG, Harron DW, Shanks RG.
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [Abstract] [Full Text] [Related]

  • 6. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T, van der Does R, Schräder R, Landgraf H, Kober G.
    J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [Abstract] [Full Text] [Related]

  • 7. Stereoselective effects of (R)- and (S)-carvedilol in humans.
    Stoschitzky K, Koshucharova G, Lercher P, Maier R, Sakotnik A, Klein W, Liebmann PM, Lindner W.
    Chirality; 2001 Jul; 13(7):342-6. PubMed ID: 11400186
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
    Cubeddu LX, Fuenmayor N, Varin F, Villagra VG, Colindres RE, Powell JR.
    J Cardiovasc Pharmacol; 1987 Jul; 10 Suppl 11():S81-4. PubMed ID: 2454374
    [Abstract] [Full Text] [Related]

  • 9. Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study.
    Nieminen T, Ylitalo R, Kööbi T, Ylitalo P, Kähönen M.
    Arzneimittelforschung; 2005 Jul; 55(4):205-11. PubMed ID: 15901043
    [Abstract] [Full Text] [Related]

  • 10. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
    Tham TC, Guy S, McDermott BJ, Shanks RG, Riddell JG.
    Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC, Finch MJ, Harron DW, Meredith PA, McDevitt DG, Shanks RG.
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [Abstract] [Full Text] [Related]

  • 12. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R, Koulu M, Allonen H.
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [Abstract] [Full Text] [Related]

  • 13. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G, Sampieri L, Cuspidi C, Boselli L, Terzoli L, Rupoli L, Zanchetti A.
    J Cardiovasc Pharmacol; 1987 Jun; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [Abstract] [Full Text] [Related]

  • 14. Comparative effect of propranolol and labetalol on isometric exercise and cold stress induced increase in arterial blood pressure.
    Pandhi P, Sharma PL, Sharma BK, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):249-53. PubMed ID: 3525424
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological effects of labetalol in man.
    Richards DA.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation.
    Ruffolo RR, Sauermelch CF, Willette RN.
    Eur J Clin Pharmacol; 1990 Aug; 38 Suppl 2():S112-4. PubMed ID: 1974499
    [Abstract] [Full Text] [Related]

  • 17. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [Abstract] [Full Text] [Related]

  • 18. Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol.
    Ishibashi T, Ohta H, Jin H, Mitomi A, Tatebe S, Nakazawa M, Imai S.
    Arzneimittelforschung; 1989 Oct; 39(10):1225-8. PubMed ID: 2575385
    [Abstract] [Full Text] [Related]

  • 19. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 20. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO, Oyuga HW, Njeru EK.
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.